FRG Family Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
3,080
-50
| -2% | -$22.3K | 0.24% | 67 |
|
|
2025
Q1 | $1.52M | Sell |
3,130
-105
| -3% | -$50.9K | 0.29% | 55 |
|
|
2024
Q4 | $1.3M | Buy |
3,235
+30
| +0.9% | +$12.1K | 0.24% | 65 |
|
|
2024
Q3 | $1.49M | Sell |
3,205
-12
| -0.4% | -$5.58K | 0.27% | 60 |
|
|
2024
Q2 | $1.53M | Hold |
3,217
| – | – | 0.3% | 54 |
|
|
2024
Q1 | $1.26M | Sell |
3,217
-75
| -2% | -$29.5K | 0.25% | 63 |
|
|
2023
Q4 | $1.34M | Hold |
3,292
| – | – | 0.27% | 59 |
|
|
2023
Q3 | $1.14M | Buy |
3,292
+30
| +0.9% | +$10.4K | 0.26% | 65 |
|
|
2023
Q2 | $1.15M | Buy |
3,262
+10
| +0.3% | +$3.52K | 0.25% | 65 |
|
|
2023
Q1 | $1.02M | Sell |
3,252
-245
| -7% | -$77.2K | 0.23% | 75 |
|
|
2022
Q4 | $1.01M | Hold |
3,497
| – | – | 0.24% | 77 |
|
|
2022
Q3 | $1.01M | Sell |
3,497
-43
| -1% | -$12.5K | 0.25% | 67 |
|
|
2022
Q2 | $998K | Buy |
3,540
+100
| +3% | +$28.2K | 0.23% | 72 |
|
|
2022
Q1 | $898K | Buy |
3,440
+20
| +0.6% | +$5.22K | 0.17% | 79 |
|
|
2021
Q4 | $751K | Buy |
3,420
+215
| +7% | +$47.2K | 0.14% | 86 |
|
|
2021
Q3 | $581K | Buy |
3,205
+145
| +5% | +$26.3K | 0.11% | 96 |
|
|
2021
Q2 | $617K | Buy |
+3,060
| New | +$617K | 0.12% | 96 |
|